| scholarly article | Q13442814 |
| P50 | author | Claudiu T Supuran | Q28211545 |
| Srinivas Angapelly | Q114313409 | ||
| Pavitra S Thacker | Q114313418 | ||
| Andrea Angeli | Q56961188 | ||
| Mohammed Arifuddin | Q88417901 | ||
| P2093 | author name string | Priti Singh | |
| Baijayantimala Swain | |||
| P2860 | cites work | Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste | Q27647390 |
| Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action | Q27667745 | ||
| Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo | Q27676887 | ||
| Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases | Q27683603 | ||
| Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 | ||
| The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C | Q28646334 | ||
| Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors | Q33227647 | ||
| Carbonic anhydrases as drug targets--an overview | Q36822597 | ||
| Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas | Q91453043 | ||
| Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors | Q93065311 | ||
| Carbonic anhydrase inhibitors developed through 'click tailing'. | Q37785570 | ||
| Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 | ||
| (In)organic anions as carbonic anhydrase inhibitors | Q37970856 | ||
| Structure-based drug discovery of carbonic anhydrase inhibitors | Q37999063 | ||
| Sulfonamides: a patent review (2008 - 2012). | Q38018632 | ||
| Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests. | Q38246901 | ||
| How many carbonic anhydrase inhibition mechanisms exist? | Q38653464 | ||
| 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells | Q38887024 | ||
| Structure and function of carbonic anhydrases | Q38894649 | ||
| Advances in structure-based drug discovery of carbonic anhydrase inhibitors | Q38991378 | ||
| Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms. | Q39246954 | ||
| Carbonic Anhydrase Inhibition with Benzenesulfonamides and Tetrafluorobenzenesulfonamides Obtained via Click Chemistry | Q42808032 | ||
| Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides | Q44366527 | ||
| Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors. | Q44485853 | ||
| Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. | Q44794255 | ||
| Kinetic properties and affinities for sulfonamide inhibitors of an α-carbonic anhydrase (CruCA4) involved in coral biomineralization in the Mediterranean red coral Corallium rubrum | Q46275100 | ||
| Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis | Q46544659 | ||
| In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes | Q46737388 | ||
| Palladium(II)-Catalyzed Directed anti-Hydrochlorination of Unactivated Alkynes with HCl. | Q46838591 | ||
| Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties | Q47176240 | ||
| Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? | Q47692161 | ||
| Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors | Q47719833 | ||
| Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides | Q48017394 | ||
| 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. | Q48030765 | ||
| Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases. | Q48110370 | ||
| Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor. | Q49332625 | ||
| 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors. | Q50906282 | ||
| 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. | Q51094113 | ||
| Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors. | Q51284606 | ||
| Carbonic anhydrase activators. | Q51767411 | ||
| Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators. | Q52375853 | ||
| Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates. | Q54038844 | ||
| New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII. | Q54664988 | ||
| Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors. | Q55531603 | ||
| Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides. | Q55603619 | ||
| Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates | Q57023564 | ||
| Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors | Q57279715 | ||
| Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations | Q57909147 | ||
| Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity, and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups | Q57909155 | ||
| Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors | Q58700155 | ||
| Carbonic Anhydrase Inhibitors: Clash with Ala65 as a Means for Designing Inhibitors with Low Affinity for the Ubiquitous Isozyme II, Exemplified by the Crystal Structure of the Topiramate Sulfamide Analogue† | Q58863277 | ||
| Carbonic Anhydrase Inhibitors: Perfluoroalkyl/Aryl-Substituted Derivatives of Aromatic/Heterocyclic Sulfonamides as Topical Intraocular Pressure-Lowering Agents with Prolonged Duration of Action | Q58863330 | ||
| Carbonic Anhydrase Inhibitors. Synthesis of Water-Soluble, Topically Effective, Intraocular Pressure-Lowering Aromatic/Heterocyclic Sulfonamides Containing Cationic or Anionic Moieties: Is the Tail More Important than the Ring?1 | Q58863343 | ||
| Carbonic anhydrase inhibitors | Q58863345 | ||
| Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one | Q60888687 | ||
| Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme | Q61657236 | ||
| Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring? | Q73120417 | ||
| A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing" | Q79299455 | ||
| Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy | Q86152299 | ||
| 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII | Q86934627 | ||
| Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors | Q87514980 | ||
| Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors | Q87689379 | ||
| Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors | Q88149103 | ||
| Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018) | Q88569851 | ||
| Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines | Q88614584 | ||
| Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018) | Q90735662 | ||
| Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases | Q91269702 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 1199-1209 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors | |
| P478 | volume | 34 |
Search more.